Top Markets
#1 Fake World Assets Fake World Assets +10.69%
#2 B3 (Base) B3 (Base) +10.34%
#3 Janction Janction +9.46%
#4 Verus Coin Verus Coin +7.95%
#5 TENDIES TENDIES +6.38%
#6 GoPlus Security GoPlus Security +4.67%
#7 龙虾 (Lobster) 龙虾 (Lobster) +4.03%
#8 Provenance Blockchain Provenance Blockchain +3.76%
#9 Everything Everything +3.72%
#10 OVERTAKE OVERTAKE +3.30%
Coin of the day
Fake World Assets Fake World Assets
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Kineta, Inc. Kineta, Inc.

Kineta, Inc.

KA
Peringkat dalam Saham #34153
Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing... Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships with a variety of entities, including private companies, government bodies, and other industry stakeholders. Among its significant strategic collaborators are Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Established in 2007, Kineta, Inc. was previously known as Lecura, Inc. and has its base of operations in Seattle, Washington.
Harga Saham
$0.617
Terakhir disinkronkan: 2024-10-14
Kapitalisasi Pasar
$6.13M
Perubahan (1 hari)
0.49%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Kineta, Inc. (KA)

Kategori

Healthcare
Riwayat harga saham Kineta, Inc. (KA)
Harga penutupan tertinggi: $0.60 pada 2024-10-01

Harga penutupan terendah: $660.46 pada 2016-02-01
Riwayat harga saham Kineta, Inc. dari 2016 hingga 2026
Performa harga saham tahunan
Tahun Performa
2024 -85.01%
2023 -51.01%
2022 -54.76%
2021 -84.38%
2020 -61.46%
2019 -35.59%
2018 -2.25%
2017 -61.49%
2016 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE